Revelation Biosciences Inc (REVB NASDAQ) stock market data APIs
$2.8541
0.07(2.5%)
as of March 18, 2025
Revelation Biosciences Inc Financial Data Overview
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
Prev. Close
2.7834
Open
2.8541
High
2.8845
Low
2.5892
52 wk Range
2.36-47.36
Market Cap
2 716 K
Shares Outstanding
905 K
EPS
-4.98
Beta
0.177
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revelation Biosciences Inc data using free add-ons & libraries
Get Revelation Biosciences Inc Fundamental Data
Revelation Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -7 947 186
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-20
- EPS/Forecast: -10.32
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revelation Biosciences Inc News
New
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.43%
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Technology, Consumer Goods and Consumer Services sectors led shares lower. At the close in NYSE, the Dow Jones I...
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Basic Materials, Consumer Services ...
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process Diffusion received bids from more than 15 companies particip...
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the develop...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
